Last update:

Medications news

Medications

Studies support use of daily antibiotic to prevent STDs in high-risk groups

It's long been known that popping the antibiotic doxycycline within 72 hours of a risky sexual encounter can greatly reduce a person's risk for a sexually transmitted infection (STI).

Medications

Postexposure prophylaxis with nirmatrelvir-ritonavir does not cut COVID-19 infection

Postexposure prophylaxis with nirmatrelvir-ritonavir for five or 10 days does not reduce the risk for symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published in the ...

Medications

New analgesic could replace opioids over the long term

Opioids have long been known as natural substances with substantial pharmacological effects and have been used as effective painkillers. A very prominent example is morphine, which was first isolated and synthesized in the ...

Medications

Study reveals how an anesthesia drug induces unconsciousness

There are many drugs that anesthesiologists can use to induce unconsciousness in patients. Exactly how these drugs cause the brain to lose consciousness has been a longstanding question, but MIT neuroscientists have now answered ...

Medications

Opioid prescribing to reduce overdoses, misuse

New research aims to help reduce the quantity of unused prescription opioids after emergency department visits and lessen the risk of opioid misuse and overdose. The study, titled "Opioid prescribing requirements to minimize ...

Medications

FDA approves Zoryve for atopic dermatitis

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).